+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


China Graves' disease Market 2019-2025

  • ID: 5116624
  • Report
  • February 2020
  • Region: China
  • Orion Market Research Private Limited


  • Abbott Laboratories Inc.
  • Allergan PLC
  • Eli Lilly and Co.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co. Inc.
China Graves’ disease Market Size, Share & Trends Analysis Report by Diagnosis (Ultrasound, Imaging Tests, Radioactive Iodine Uptake, and Blood Sample), by Treatment (Anti- Thyroid Medication, Radioactive Iodine Therapy, and Surgery) Forecast Period 2019-2025.

China Graves’ disease market is expected to grow at a CAGR of around 5.8% during the forecast period. Chinese Economy is growing considerably, and it has become a preferred destination for setting business due to cheap labor, improved infrastructure, and a large customer base. China’s market has both medium and long-term potential due to its large market size, aging population, fluctuating disease profile and rapidly improving life. The Chinese economy is becoming an R&D-intensive economy which is the major factor for the growth of the life science industry of China, and in turns affects China Graves’ disease market. Along with this, government support in the country is also affecting the growth of the market. The corporate tax rate in China is 16% as compared with other countries including India at around 35%. China has a large number of pharmaceutical and medical device companies as it is the manufacturing hub for pharmaceutical drugs base supplies.

Further, the prevalence of diabetes in China is increasing at an alarming rate, owing to the increasing geriatric population in the country along with unhealthy dietary habits and lack of physical activity. According to IDF, China has the largest number of people suffering from diabetes. Moreover, there are over 46,900 children and adolescents suffering from type-1 diabetes, owing to the large population of individuals of this age group in the country. Such a high prevalence and incidence rate of diabetes in the country possesses a high risk for the development of Grave’s disease in the patients, thus influencing the China Graves’ disease market.

Further, the footprints of the key players such as Abbott Laboratories Inc., Allergan PLC, Eli Lilly and Co., GlaxoSmithKline PLC, Merck & Co. Inc., Mylan NV, Novartis International AG including other regional players are also driving the China Graves’ disease market. Besides, there were numerous activities done for the development of an improved method for the establishment of a model of Graves' disease in BALB/c mice, and various other research activities.

Research Methodology:

The market study of the China Graves’ disease market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. China Graves’ Disease Market Research and Analysis by Diagnosis
2. China Graves’ Disease Market Research and Analysis by Treatment

The Report Covers:
  • Comprehensive Research Methodology of the China Graves’ disease market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the China Graves’ disease market.
  • Insights about market determinants which are stimulating the China Graves’ disease market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories Inc.
  • Allergan PLC
  • Eli Lilly and Co.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Macleods Pharmaceuticals Ltd.
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown